|
EDITOR IN CHIEF
Alberto Corsini
Editorial Board
Maurizio Averna
Michel Farnier
Meral Kayikcioglu
Luis Masana
Andrea Poli
Evgeny V. Shlyakhto
Margus Viigimaa
Editorial office
Olga Brigida
Elisa Gardini
Angela Pirillo
Roberto Zecca
Journal Manager
Danilo Ruggeri
ISSN
2785-7115
Secretariat
Via Balzaretti 7
20133 - Milano
Invia email
Attribution-NonCommercial-NoDerivatives
4.0 International
(CC BY-NC-ND 4.0)
|
The European Atherosclerosis Journal is a new international, peer-reviewed, fully open access, four-monthly journal covering all topics within atherosclerosis and cardiovascular disease areas. The Journal aims to publish high quality research and follows strict rules to assess originality and best practices for authorship and disclosure of potential conflicts of interest.
The European Atherosclerosis Journal is the international official journal of SITeCS (Italian Society for Experimental and Clinical Therapeutics).
European Atherosclerosis Journal is an international journal that publishes papers in the field of atherosclerosis and cardiovascular disease, from basic research to clinical and translational studies. Meta-analysis and systematic reviews will also be accepted. Papers will be considered for publication based on originality and contribution to the field. The journal will consider for publication original articles (experimental and clinical), review articles, methodology papers, editorials, letters to the Editor, viewpoints, congress/conference reports.
European Atherosclerosis Journal is published by SITeCS under a Creative Commons Attribution Non-Commercial No Derivatives license (CC BY-NC-ND)
© The Author(s). Published by SITeCS
Copyright retained by the author but commercial rights transferred to the publisher. For commercial re-use please contact the Editorial Office.
The Editorial Board invites you to submit a paper.  European Atherosclerosis Journal - Guidelines for Authors in pdf format
Current issue:
• EAJ Vol 2, No 1 (2023)
In this issue:
• |
Original article
Lipid-lowering treatment and LDL-C goal attainment in high and very high cardiovascular risk patients: Evidence from the SANTORINI study-The Italian experience
Marcello Arca, Paolo Calabrò, Anna Solini, Angela Pirillo, Rosanna Gambacurta, Kausik K. Ray, Alberico L. Catapano, the SANTORINI Italian Group*
EAJ 2023;2:1-13
|
• |
Congress/conference report
Spring Meeting of the Young Researchers of SID, SIIA, SIMI, SIPREC, SISA
Chiara Pavanello, Vanessa Bianconi, Lorenzo Da Dalt, Giovanna Gallo, Costantino Mancusi, Michele Ciccarelli, Alessandro Maloberti, Francesco Spannella, Fabio Fimiani, Damiano D’Ardes, Rosa Lombardi, Giovanni Talerico, Massimiliano Cavallo
EAJ 2023;2:14-17
|
| • |
Congress/conference report - Selected Abstracts
EAJ 2023;2:18-26
How age and gender affect hemodynamic forces in healthy subjects
Lorenzo Airale, Simona Votta, Anna Colomba, Giulia Mingrone, Arianna Paladino, Anna Astarita, Marco Cesareo, Cinzia Catarinella, Francesca Novello, Alberto Milan
EAJ 2023;2:18
Statin-Associated Muscle Symptoms: Clinical Index in a hypertensive population candidated to lipid-lowering therapy but not taking statins
Riccardo Sarzani, Federico Giulietti, Massimiliano Allevi, Silvia Sarnari, Romina Alessandroni, Chiara Di Pentima, Francesco Spannella
EAJ 2023;2:19
Biomarkers of mitochondrial dysfunction and inflammaging in older adults and blood pressure variability
Leonardo Bencivenga, Mathilde Strumia, Yves Rolland, Sandrine Andrieu, Bruno Vellas, Philipe De Souto Barreto, Laure Rouch, for the MAPT/D. S. A. group
EAJ 2023;2:19
Irisin administration restores beta-cell functional mass in a mouse model of type 2 diabetes
Anna Borrelli, Nicola Marrano, Giuseppina Biondi, Martina Rella, Luca Roberto, Angelo Cignarelli, Sebastio Perrini, Luigi Laviola, Francesco Giorgino, Annalisa Natalicchio
EAJ 2023;2:20
Acute ischemic stroke: how to investigate the association between disease etiology and gene expression profiles
Giulia Cassioli, Ada Kura, Alessandro Sodero, Elena Sticchi, Alberto Magi, Samuele Suraci, Rosina de Cario, Arturo Consoli, Andrea Rosi, Sergio Nappini, Leonardo Renieri, Nicola Limbucci, Benedetta Piccardi, Francesco Arba, Cristina Sarti, Domenico Inzitari, Salvatore Mangiafico, Rossella Marcucci, Anna Maria Gori, Betti Giust
EAJ 2023;2:20
Successful treatment with lomitapide in a patient with homozygous familial hypercholesterolemia and severe fatty liver disease
Alessia Cavicchioli, Simonetta Lugari, Michela D’Avino, Francesca Carubbi, Fabio Nascimbeni
EAJ 2023;2:21
Optimization of glucose control drives improvement of NAFLD independent of weight loss in people with T2D
Santo Colosimo, Garry D. Tan, Maria Letizia Petroni, Simona Bertoli, Giulio Marchesini, Jeremy W. Tomlinson
EAJ 2023;2:21
Exosomal miRNAs targeting NLRP3 inflammasome platform are associated with radiologic sequelae in survivors of COVID-19-associated acute respiratory distress syndrome
Rosa Curcio, Giulia Poli, Consuelo Fabi, Chiara Sugoni, Maria Bruna Pasticci, Roberto Ferranti, Monica Rossi, Ilenia Folletti, Leandro Sanesi, Edoardo Santoni, Irene Dominioni, Massimiliano Cavallo, Giovanni Morgana, Lorenzo Mordeglia, Giovanni Luca, Giacomo Pucci, Stefano Brancorsini, Gaetano Vaudo
EAJ 2023;2:22
Exploring the role of FXR signaling in maintaining ileal mucosa integrity in subjects with altered glucose tolerance conditions
Francesca De Vito, Evelina Suraci, Raffaella Marasco, Francesco Andreozzi, Marta L. Hribal, Francesco Luzza, Giorgio Sesti, Teresa V. Fiorentino
EAJ 2023;2:22
Change over time of lipid profile relates to steroid treatment but not to an inflammatory state in Granulomatosis with poliangioitis polyangiitis (GPA)
Marialuisa S. Marozzi, Teresa Panebianco, Antonio Vacca, Valeria Dipaola, Silvia Noviello, Antonio Giovanni Solimando, Sebastiano Cicco
EAJ 2023;2:23
Impact of immune system humanization on atherosclerosis in dyslipidemic Rag2-KO/IL2rg-KO/CD47-KO/LDL-R KO mice
Fabrizia Bonacina, Jasmine Nour, Annalisa Moregola, Gianluigi Inzoli, Ottavia Terenghi, Francesca Fantini, Giuseppe Danilo Norata
EAJ 2023;2:23
Dapagliflozin counteracts the pro-apoptotic effects of the secretome of visceral adipose cells from obese subjects in human cardiac progenitor cells via the SGLT2 co-transporter
Giuseppe Palma , Cristina Caccioppoli, Rossella D’Oria, Valentina Annamaria Genchi, Isabella Calderoni, Antonio Braun, Giuseppe Santarpino, Aldo Domenico Milano, Angelo Cignarelli, Annalisa Natalicchio, Luigi Laviola, Angela Pezzolla, Francesco Giorgino, Sebastio Perrini
EAJ 2023;2:24
Extreme cardiovascular risk in cardiological rehabilitation: prevalence and impact on patient’s functional improvement
Alfonso Riccio, Eleonora Senini, Saverio Fabbri, Claudio Ciampi, Matteo Regazzetti, Massimiliano Monticelli, Roberto Pirola, Cristina Giannattasio
EAJ 2023;2:24
Role of ASGR1 on obesity and metabolic syndrome
Monika Svecla, Annalisa Moregola, Lorenzo Da Dalt, Jasmine Nour, Andrea Baragetti, Patrizia Uboldi, Fabeizia Bonacina, Giuseppe Danilo Norata
EAJ 2023;2:25
Thrombocytopenia and Kidney disease, two possible hallmark of FCS phenotype: preliminary evidence from a cohort study
Daniele Tramontano, Simone Bini, Alessia Di Costanzo, Ilenia Minicocci, Stella Covino, Marcello Arca, Laura D’Erasmo
EAJ 2023;2:25
In vitro and in vivo studies on novel pcsk9 inhibitors as pharmacological approach for the treatment of alzheimer’s disease
Martina Ugolotti, Bianca Papotti, Francesca Zimetti, Ilaria Zanotti, Martina Bodria, Antonietta Vilella, Daniela Giuliani, Lisa Giannessi, Lisa Elviri, Maria Giovanna Lupo, Nicola Ferri, Marco Radi, Franco Bernini
EAJ 2023;2:26
Effect of lipid-lowering therapies on lipoprotein(a) levels: a meta-analysis of randomized controlled trials
Sining Xie, Federica Galimberti, Elena Olmastroni, Alberico L. Catapano, Manuela Casula
EAJ 2023;2:26
|
|
|
|
Archives 2022
• EAJ Vol 1, No 3 (2022)
• |
Review
Are we seeing the light at the end of the tunnel for high lipoprotein(a)?
Meral Kayikcioglu, Hasan Selcuk Ozkan, Lale Tokgozogluy
EAJ 2022;1:54-68
|
• |
Review
Nutraceutical alternatives to red yeast rice extract/monacolin K for moderate hypercholesterolaemia: Current evidence and knowledge gaps
Laura Comi, Claudia Giglione, Fationa Tolaj, Cinzia Parolini, Chiara Olivieri, Marco Ruzza, Valentina Tollemeto, Maria Zurlo, Federico Pialorsi, Antonio Seneci, Paolo Magn
EAJ 2022;1:69-78
|
• |
|
• |
Congress/conference report - Selected Abstracts
EAJ 2022;1:82-83
Effect of the deletion of prenylcysteine-oxidase 1 (PCYOX1) on arterial thrombosis in an animal model
Patrizia Amadio, Cristina Banfi, Marta Zarà, Maura Brioschi, Stefania Ghilardi, Leonardo Sandrini, Silvia Stella Barbieri
Impact of dietary choline on lipid metabolism and atherosclerosis development in apoEKO mice deficient or overexpressing apolipoprotein A-I
Alice Colombo, Marco Busnelli, Stefano Manzini, Elsa Franchi, Mariel Garcia Rivera, Jennifer Kirwan, Giulia Chiesa
Role of histone deacetylase 3 (HDAC3) in adipose tissue metabolism and immunophenotype
Lara Coppi, Carolina Peri, Fabrizia Bonacina, Raffaella Longo, Dalma Cricrí, Silvia Pedretti, Rui Silva, Ilenia Severi, Antonio Giordano, G. Danilo Norata, Alberico L. Catapano, Nico Mitro, Emma De Fabiani, Maurizio Crestani
Combining family history of coronary heart disease and individual genetic predisposition to predict the risk of major coronary events
Elena Olmastroni, Federica Galimberti, Alberico L. Catapano, Brian Ference
|
|
|
|
• EAJ Vol 1, No 2 (2022)
• EAJ Vol 1, No 1 (2022)
|
17° Congresso Nazionale
